Replies to post #50235 on Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

If K does a fraction of what it has shown. That pps is an insult. IMO. I'm on the same boat as BK. The numbers can become unreal if a couple of these drugs pan out.

Great to be aside you and all the others here.

[TheBunny]

A $20. ps 'buyout' IMO would be unacceptable to corporate. They know what they have now, and soon many more will know what CTIX has to offer.

Selling CTIX for $20. a share would be like a BK fire sale, worse than Polymedx.

would a $2 Billion price tag be unrealistic for a company with so many potential drugs in clinical trials with such large potential profitable markets?!? Moreover, a $2 Billion price tag would translate to approximately a $20 per share price.

[Phoenix300]

MD Big Kahuna addressed this and his thoughts were that if all goes as plan Kevetrin would be worth 15 billion alone and add in P, B and the pipeline and the total would be 25 Billion plus

his post was 49599

[BonelessCat]

IMO, the bidding will start at $15 billion. A K license after Phase 1 and approval for Phase 2/3a will be worth $2 billion, and that is only for the license for all K uses. There are many recent examples supporting this price.